ScholarIQanswers from OpenAlex

Travel, Treatment Choice, and Survival Among Breast Cancer Patients: A Population-Based Analysis

PaperCitations, authors & open-access status

Travel, Treatment Choice, and Survival Among Breast Cancer Patients: A Population-Based Analysis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Travel, Treatment Choice, and Survival Among Breast Cancer Patients: A Population-Based Analysis have?

ScholarIQcitation count

Travel, Treatment Choice, and Survival Among Breast Cancer Patients: A Population-Based Analysis has 35 citations in the OpenAlex counts ScholarIQ stores.

When was Travel, Treatment Choice, and Survival Among Breast Cancer Patients: A Population-Based Analysis published?

ScholarIQyear

Travel, Treatment Choice, and Survival Among Breast Cancer Patients: A Population-Based Analysis has 2021 year in the ScholarIQ index.

What is the open-access status of Travel, Treatment Choice, and Survival Among Breast Cancer Patients: A Population-Based Analysis?

ScholarIQoa status

Travel, Treatment Choice, and Survival Among Breast Cancer Patients: A Population-Based Analysis has gold oa status in the ScholarIQ index.

What is the DOI of Travel, Treatment Choice, and Survival Among Breast Cancer Patients: A Population-Based Analysis?

ScholarIQdoi

The DOI for Travel, Treatment Choice, and Survival Among Breast Cancer Patients: A Population-Based Analysis is on the source record.

What is the PMID of Travel, Treatment Choice, and Survival Among Breast Cancer Patients: A Population-Based Analysis?

ScholarIQpmid

The PMID for Travel, Treatment Choice, and Survival Among Breast Cancer Patients: A Population-Based Analysis is on the source record.

What is the OpenAlex record for Travel, Treatment Choice, and Survival Among Breast Cancer Patients: A Population-Based Analysis?

ScholarIQopenalex

The OpenAlex for Travel, Treatment Choice, and Survival Among Breast Cancer Patients: A Population-Based Analysis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial